Oncovida - Santiago

Santiago 8320000

1 studies enrolling now · 2 studies all time

What they study most

Anaplastic Lymphoma Kinase-positive, Early Breast Cancer, Non-small Cell Lung Cancer

Studies at this site

• Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC — Recruiting now
• A Study Evaluating the Efficacy and Safety of Adjuvant Giredestrant Compared With Physician's Choice of Adjuvant Endocrine Monotherapy in Participants With Estrogen Receptor-Positive, HER2-Negative Early Breast Cancer (lidERA Breast Cancer) — Running, not enrolling